Clin Neurophysiol. 2021 Dec;132(12):3010-3018. doi: 10.1016/j.clinph.2021.08.021. Epub 2021 Oct 08.
Ketamine induces EEG oscillations that may aid anesthetic state but not dissociation monitoring.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Shubham Chamadia, Jacob Gitlin, Jennifer Mekonnen, Breanna R Ethridge, Reine Ibala, Katia M Colon, Jason Qu, Oluwaseun Akeju
Affiliations
Affiliations
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: [email protected].
PMID: 34715426
PMCID: PMC8629941 DOI: 10.1016/j.clinph.2021.08.021
Abstract
OBJECTIVE: Ketamine is an anesthetic drug associated with dissociation. Decreased electroencephalogram alpha (8-13 Hz) and low-beta (13-20 Hz) oscillation power have been associated with ketamine-induced dissociation. We aimed to characterize surface electroencephalogram signatures that may serve as biomarkers for dissociation.
METHODS: We analyzed data from a single-site, open-label, high-density surface electroencephalogram study of ketamine anesthesia (2 mg/kg, n = 15). We assessed dissociation longitudinally using the Clinician Administered Dissociation States Scale (CADSS) and administered midazolam to attenuate dissociation and enable causal inference. We analyzed electroencephalogram power and global coherence with multitaper spectral methods. Mixed effects models were used to assess whether power and global coherence signatures of ketamine could be developed into dissociation-specific biomarkers.
RESULTS: Compared to baseline, ketamine unresponsiveness was associated with increased frontal power between 0.5 to 9.3 Hz, 12.2 to 16.6 Hz, and 24.4 to 50 Hz. As subjects transitioned into a responsive but dissociated state (mean CADSS ± SD, 22.1 ± 17), there was a decrease in power between 0.5 to 10.3 Hz and 11.7 to 50 Hz. Midazolam reduced dissociation scores (14.3 ± 11.6), decreased power between 4.4 to 11.7 Hz and increased power between 14.2 to 50 Hz. Our mixed-effects model demonstrated a quadratic relationship between time and CADSS scores. When models (frontal power, occipital power, global coherence) were reanalyzed with midazolam and electroencephalogram features as covariates, only midazolam was retained.
CONCLUSIONS: Ketamine is associated with structured electroencephalogram power and global coherence signatures that may enable principled anesthetic state but not dissociation monitoring.
SIGNIFICANCE: A neurophysiological biomarker for dissociation may lead to a better understanding of neuropsychiatric disorders.
Copyright © 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.
Keywords: CADSS; Dissociation; EEG; Ketamine; Spectral
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: OA has received speaker's honor
References
- J Nerv Ment Dis. 1997 Dec;185(12):755-60 - PubMed
- J Anxiety Disord. 2004;18(4):435-58 - PubMed
- CNS Neurosci Ther. 2013 Jun;19(6):396-402 - PubMed
- Anesthesiology. 2020 Nov 1;133(5):970-972 - PubMed
- Elife. 2021 May 10;10: - PubMed
- Front Syst Neurosci. 2014 Jul 01;8:114 - PubMed
- Curr Opin Neurobiol. 2017 Jun;44:178-185 - PubMed
- Ann Emerg Med. 2011 Feb;57(2):109-114.e2 - PubMed
- Clin Neurophysiol. 2016 Jun;127(6):2472-81 - PubMed
- Pharmacol Biochem Behav. 2021 Feb;201:173092 - PubMed
- Clin Neurophysiol. 2016 Jun;127(6):2414-22 - PubMed
- Nature. 2020 Oct;586(7827):31-32 - PubMed
- J Trauma Stress. 1998 Jan;11(1):125-36 - PubMed
- Neuroimage. 2021 Aug 15;237:118171 - PubMed
- Anesthesiology. 2020 Nov 1;133(5):1021-1028 - PubMed
- Can J Anaesth. 2000 Sep;47(9):866-74 - PubMed
- Nature. 2020 Oct;586(7827):87-94 - PubMed
- Br J Anaesth. 2019 Aug;123(2):206-218 - PubMed
- Am J Psychiatry. 2016 Aug 1;173(8):816-26 - PubMed
- Mol Psychiatry. 2020 Jul;25(7):1592-1603 - PubMed
- J Affect Disord. 2018 Feb;227:11-16 - PubMed
- Nat Commun. 2020 Dec 22;11(1):6431 - PubMed
- Anesthesiology. 2014 Nov;121(5):990-8 - PubMed
- Anesthesiology. 2010 Sep;113(3):678-84 - PubMed
- Front Hum Neurosci. 2016 Nov 29;10:612 - PubMed
- Clin Psychol Rev. 2014 Aug;34(6):482-95 - PubMed
- Front Pharmacol. 2016 Sep 27;7:348 - PubMed
- Eur J Pharmacol. 2019 Oct 5;860:172547 - PubMed
- Br J Anaesth. 2018 Jul;121(1):249-259 - PubMed
- Front Syst Neurosci. 2017 May 30;11:38 - PubMed
- Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):330-57 - PubMed
- Anesthesiology. 2015 Oct;123(4):937-60 - PubMed
- Annu Rev Neurosci. 2011;34:601-28 - PubMed
- Commun Biol. 2019 Nov 15;2:415 - PubMed
- Br J Anaesth. 2007 Sep;99(3):389-95 - PubMed
Publication Types
Grant support